QUICK POLL
Microsatellite Instability (MSI-H) in colon cancer has been associated with which of the following?
6th European Congress:
Perspectives in Gynecologic Oncology
30 - 31 January 2009
Nice, France
Continuing Medical Education
EACCME Accreditation
Imedex, LLC is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be.
The 6th European Congress: Perspectives in Gynecologic Oncology is designated for a maximum of 7 hours of European external CME credits. Each medical specialist should claim only those hours of credit that she/he actually spent in the educational activity.
EACCME credits are recognized by the American Medical Association toward the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA Category 1 creditTM, contact the AMA.
Instructions for converting EACCME Credit to AMA PRA Category 1 CreditTM
To apply for conversion of EACCME credit to AMA PRA Category 1 CreditTM, the attendee must complete the Application for EACCME Credit Conversion at www.ama-assn.org and submit (1) the completed application by fax or mail (2) along with a copy of the EACCME credit certificate and (3) processing fee ($20 for AMA members, $40 for non-members). A certificate of AMA PRA Category 1 CreditTM will be mailed within 4 weeks. If the physician/attendee has further questions, they may contact the AMA’s CPPD at pra@ama-assn.org
Who Should Attend
This educational activity is intended for gynecologists, oncologists, radiation therapists, pathologists, and other practitioners involved in the diagnosis and management of gynecologic cancers including ovarian, endometrial, and cervical cancers.
Objectives
After successfully completing this educational activity, participants should be able to:
- Assess the impact of recently available human papilloma virus (HPV) vaccines on the prevention of cervical cancer
- Apply advances in chemotherapy strategies and surgical approaches to clinical practice for advanced and metastatic cervical cancer
- Summarize advances in and the role of adjuvant radiotherapy and chemotherapy in the management of endometrial cancer
- Discuss recent clinical advances among uterine sarcomas, carcinosarcomas, and vulvar carcinoma as they relate to the therapeutic management of these diseases
- Determine the optimal surgical management of ovarian cancer based on disease stage and clinical presentation
- Discuss clinical data that may provide evidence to support new treatment options in the management of ovarian cancer
- Formulate the most favorable approach in the management of gynecological cancers by incorporating expert perspectives based upon emerging data
Friday, 30 January 2009
13:00
Welcome and introduction
Andreas du Bois, MD, PhD
Session I: Cervical Cancer
Moderator: Ignace Vergote, MD, PhD
13:05
HPV vaccination and screening in cervical cancer
F. Xavier Bosch, MD
13:30
Case presentation and expert discussion
FIGO 2B: Which patients are suitable for surgery and which patients should receive radiotherapy?
Radiation Oncologist’s perspective:
Gillian Thomas, MD
Surgeon’s perspective:
Nicoletta Colombo, MD
14:30
Case presentation and expert discussion
Metastatic disease: Management of recurrent disease
Surgeon’s perspective:
Stefano Greggi, MD, PhD
Medical Treatment perspective:
Bradley J. Monk, MD
15:30 Coffee break
Session II: Endometrial/Vulvar Cancer
Moderator: Andreas du Bois, MD, PhD
16:00
Case presentation and expert discussion
Early stage high risk management options.
FIGO IC G3 +/- LNE: Adjuvant radiotherapy
vs. chemotherapy vs. both
Radiotherapy advocate:
Carien L. Creutzberg, MD, PhD
Chemotherapy advocate:
Thomas Högberg, MD, PhD
17:00
Update on the treatment of advanced/recurrent
endometrial cancer – What about new drugs?
Bradley J. Monk, MD
17: 25
Update on the management of uterine
sarcoma and carcinosarcoma
Nick Reed, MD
17:50
Update on the management of vulvar cancer
Ate van der Zee, MD, PhD
18:15
Adjourn
Saturday, 31 January 2009
Session III: Ovarian Neoplasm I
Moderator: Stanley B. Kaye, MD
9:00
Welcome and introduction
9:10
Case presentation and expert discussion
Treatment of early ovarian cancer
EORTC perspective:
Ignace Vergote, MD, PhD
MRC perspective:
Ann Marie C. Swart, MRCP, MSc
10:10
Coffee break
10:30
Advances in the management of
stromal ovarian tumors
Nicoletta Colombo, MD
10:55
Gynecologic cancer and pregnancy –
the 2008 consensus statements
Frederic Amant, MD, PhD
Keynote Address
11:20
What can we learn from the treatment of other solid tumors?
Peter G. Harper, MD, FRCP
11:50
Lunch
Session IV: Ovarian Neoplasm II
Moderator: Peter G. Harper, MD, FRCP
13:00
Case presentation and expert discussion FIGO stage III C ovarian cancer:
Timing of surgery Pro neoadjuvant:
Ignace Vergote, MD, PhD
Pro primary surgery:
Jacobus Pfisterer, MD, PhD
14:00
The role of surgery in recurrent ovarian cancer
Andreas du Bois, MD, PhD
14:25
Update on new treatment options in ovarian cancer
Stanley B. Kaye, MD
15:00
Closing remarks
Peter G. Harper, MD, FRCP
15:10
Adjourn
Registration Fees
Regular . . . . . . . . . . . . . . . . . . . . . . € 349
If payment received by 22 January 2009
Full/Onsite . . . . . . . . . . . . . . . . . . . .€ 449
If payment received after 22 January 2009
Nurses/Residents/Students . . . . .* € 99
*proof of eligibility must accompany registration
To Register:
You may register online by 22 January 2009, or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the Congress. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Payment:
To pre-register, registration and payment must be received no later than 22 January 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: 6th European Congress: Perspectives in Gynecologic Oncology A049.01. An attendee is not registered until full payment is received. Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.
Registration Fee Inclusions:
Registration fees include admittance to all scientific sessions, Congress materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation:
For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 22 January 2009. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 22 January 2009.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this Congress should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
The Palais de la Méditerranée
13-15 Promenade des Anglais
BP 1655
06011 Nice Cedex 1 France
Tel.: +33 (0) 4 92 14 77 00
Fax: +33 (0) 4 92 14 77 14
Website: http://palais.concorde-hotels.com/en/
Le Palais de la Mediterranee enjoys a magnificent location on Promenade des Anglais, the most sought after location in Nice. The grand white Art Deco façade created in the 1930s is still fully intact and has been restored to its original splendour beckoning guests inside to savour the many fascinating delights that this legendary luxury hotel has to offer. For the convenience of attendees, a limited number of rooms have been reserved until 28 December 2008 at a discounted rate of €180 single occupancy, plus tax, currently at €1.20. This rate is not guaranteed outside the Congress dates or after 28 December 2008. To reserve your room please use the Hotel Reservation Form and return it to the hotel via email at: reservation-pdlm@concorde-hotels.com or by fax at +33 4 92 14 77 27. Reservation requests received after 28 December 2008 may not be guaranteed the group rate.
Invitation
Dear Colleagues,
We are pleased to invite you to attend the 6th European Congress: Perspectives in Gynecologic Oncology, to be held 30-31 January 2009 in Nice, France. This year’s meeting promises to be an exciting educational event where case presentations and expert discussion led by key opinion leaders in the field will provide the foundation of the program content for practitioners involved in the diagnosis and management of gynecological cancers. Through this focus on case-based discussion, we will highlight practical approaches to the management of cervical, endometrial, and ovarian cancers that can be applied to clinical practice. By the conclusion of the meeting, attendees will be able to identify emerging therapies for gynecologic cancers and develop valuable strategies to integrate them into current disease management. We are excited about the learning approach of the meeting this year, and look forward to welcoming you in beautiful Nice for what is sure to be a very rewarding educational experience.
Sincerely,
Andreas du Bois, MD, PhD
Peter G. Harper, MD, FRCP
Stanley B. Kaye, MD
Ignace Vergote, MD, PhD
Organizer:
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Important Dates:
Regular Registration Deadline
22 January 2009
Presentation Dates
30-31 January 2009
Italian Participants:
Fargo International Meetings & Conventions SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078
Chairs:
Andreas du Bois, MD, PhD
Dr.-Horst-Schmidt-Kliniken
Wiesbaden, Germany
Peter G. Harper, MD, FRCP
Guy’s and St. Thomas’ Hospital
London, United Kingdom
Stanley B. Kaye, MD
The Royal Marsden Hospital
Sutton, United Kingdom
Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium
Congress Location and Registration:
The Palais de la Méditerranée
13-15 Promenade des Anglais
BP 1655
06011 Nice Cedex 1 France
Tel.: +33 (0) 4 92 14 77 00
Fax: +33 (0) 4 92 14 77 14
Website: http://palais.concorde-hotels.com/en/
The Registration and Information Desk will be staffed:
Thursday, 29 January 2009
17:00 – 19:00
Friday, 30 January 2009
11:00 – 18:00
Saturday, 31 January 2009
08:00 – 16:15
Please note: Registration on Saturday, 31 January 2009 ends at 15:30
Discounted Airfares:
Contact Congress travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and post-Congress extensions.
Tel.: +1 (888) 232-9394 or +1 (770) 261-8613
Email: judit@willtrav.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.